Year: 2020

(Bloomberg) — Bearish investors are holding on to their short bets on Moderna Inc. even as the biotech’s market value swelled by more than $25 billion this year on optimism its experimental messenger-RNA vaccine will play a part in tamping down the pandemic.Options data suggest the stock is ready for another double-digit swing over the next few weeks and with S3 Partners data showing about $1.84 billion shares shorted, bears might face fresh pain or finally claw back some losses.Moderna “was and is now a short squeeze candidate,” Ihor Dusaniwsky, S3’s managing director of predictive analytics, said in an interview.The …read more […]

Andy Serwer, Yahoo Finance’s Editor-In- Chief speaks to Alibaba President Michael Evans about Alibaba’s business and Singles Day 2020. …read more […]

The chancellor commissioned the report in July as part of efforts to cover Covid-19 costs. …read more […]

TherapeuticsMD, Inc. (NASDAQ:TXMD) just released its latest third-quarter results and things are looking bullish… …read more […]

(Bloomberg) — Small-cap drug developer Five Prime Therapeutics Inc. is on track to post one of this year’s biggest daily stock moves after reporting promising data from a mid-stage cancer study.The South San Francisco, California-based biotech firm skyrocketed as much as 349% after a combination of its drug and chemotherapy helped some patients keep their stomach cancer at bay for longer than those receiving just chemotherapy. Should this rally hold, it would be the third biggest single-day move on the New York Stock Exchange and Nasdaq Exchange, according to data compiled by Bloomberg.Its stock-surge trails a pair of micro-caps with …read more […]

It’s time to unleash the bulls, says one top market strategist. …read more […]

Neel Shah, PEAK6 Capital Management Senior Portfolio Manager joins the Yahoo Finance Live panel to talk about Alibaba’s Singles Day, the tech outlook and how the race for a vaccine is weighing on the markets. …read more […]

…read more […]

(Bloomberg) — Pfizer Inc. Chief Executive Officer Albert Bourla pocketed about $5.6 million after selling stock, the latest executive to reap the rewards of insider share transactions amid a vaccine-fueled rally for some pharmaceutical companies.Bourla disposed of more than 130,000 shares on Monday, according to a filing with the U.S. Securities and Exchange Commission. Sally Susman, executive vice president and chief corporate affairs officer at Pfizer, also offloaded about $1.8 million in stock.Pfizer’s shares soared that day after a report on results from its experimental vaccine with partner BioNTech SE. Anthony Fauci, the top U.S. infectious-disease specialist described the findings …read more […]

…read more […]

Yahoo Finance’s Myles Udland, Julie Hyman, Brian Sozzi, and Dan Howley recap Apple’s M1 chip event. …read more […]

The most you can lose on any stock (assuming you don’t use leverage) is 100% of your money. But when you pick a… …read more […]

The number crunchers at Goldman Sachs are bullish on how a COVID-19 vaccine could impact the stock market. Yahoo Finance’s Brian Sozzi weighs in. …read more […]

President-elect Joe Biden made a campaign proposal to erase $10,000 for roughly 37 million Americans who owe federally-backed student loan debt, and experts are divided on if the incoming president will be able to make good on that promise. …read more […]

Shares of Alibaba fell on Wednesday — despite setting a new record for Singles’ Day — after Beijing released draft rules defining what constitutes anti-competitive behavior for the first time ever. CFRA’s John Freeman joins Yahoo Finance Live to discuss the implications of the move for China’s big tech companies such as Alibaba and JD.com. …read more […]